Vanderbilt University Medical Center
Nashville, Tennessee, 37240, United States
NCT Number: NCT00848705
The goals of this R21 exploratory pilot and feasibility study were to: 1) design an Internet-based self-management intervention for adolescents with type 1 diabetes; 2) test that intervention in a small randomized trial to establish technical feasibility, intervention acceptability, and competence in completing the necessary recruitment and research procedures. Although not powered to detect statistically significant changes, possible outcomes of this study include improvements in problem-solving, coping, and self-management behaviors.
Looking for future studies?
Notify Me13 year–17 year
All sexes
Interventional
Early Phase 1
Nashville, Tennessee, 37240, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
diagnosed for at least 6 months, age 13-17; Internet access, parental consent -
Exclusion criteria
Any sensory deficits that would preclude seeing or hearing.
-
The intervention is an 11 week program that teaches problem solving of barriers to self-management.
Time frame: End of intervention
Time frame: end of study period
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Nih
Adolescent Self-Management of Type 1 Diabetes: an Intervention
Acronym: YourWay
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06238778
Autoimmune Diseases, Diabetes Mellitus
Huntington Beach, California, United States
View Trial DetailsNCT06236256
Autoimmune Diseases, Diabetes Mellitus
Ramat Gan, Israel
View Trial DetailsNCT03761186
Autoimmune Diseases, Diabetes Mellitus
Stockholm, Sweden
View Trial DetailsNCT07711275
Autoimmune Diseases, Diabetes Mellitus
Istanbul, Turkey (Türkiye)
View Trial Details